Fernando Moreno Antón

8PUBLICATIONS
65CO-AUTHORS
Molecular targetsClinical midwiferyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 24, 2026
Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?

|Aug 20, 2025
Correlation of HER2 levels expression through HER2 mRNA PCR vs immunohistochemistry (IHC) in hormone receptor positive (HR+)/HER2 negative (HER2-) early breast cancer.

Alfonso López de Sá, Julia Tejerina, Marta Amann

|Sep 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora

|Apr 01, 2024
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: The real-life study PALBOSPAIN.

N Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez

|Mar 11, 2024
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy.

Miguel Martín, Rachel Yoder, Roberto Salgado

|Sep 28, 2023
Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study.

Alicia Milagros de Luna Aguilar, Javier David Benitez Fuentes, Justo Ortega Anselmi

Pageof 2

Frequent Collaborators

5 joint publications

Jose Angel Garcia-Saenz

3 joint publications

Sonia Pernas

3 joint publications

Isabel Echavarria

2 joint publications

Noelia Martínez-Jañez